Internal Medicine, Hematology & Oncology · Boston, MA
NPI
1285893453
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
55 Fruit St # Street1
Boston, MA, 02114
Phone (617) 724-1124
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
957 services
Medicare patients, 2024
207
Average age 75
Drug cost, 2024
$7.6M
733 prescriptions
Company payments, 2025
$53K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gabriela S Hobbs was code 99233 (hospital e&m - subsequent), 283 times for 52 patients. In total Gabriela S Hobbs billed 957 services in 9 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 283 | 52 | $98.17 | $28K |
| 99214 Office E&M - Established | Facility | 205 | 92 | $73.61 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 154 | 88 | $13.82 | $2,128 |
| 99214 Office E&M - Established | Office | 127 | 70 | $99.24 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 86 | 58 | $13.66 | $1,175 |
| 99215 Office E&M - Established | Facility | 32 | 29 | $113.39 | $3,629 |
| 99223 Hospital E&M - Initial | Facility | 19 | 18 | $144.35 | $2,743 |
| 99239 Hospital Discharge Management | Facility | 14 | 13 | $96.33 | $1,349 |
| 99443 Telephone Services | Facility | 14 | 11 | $71.52 | $1,001 |
By year: 2022 $62K for 727 services; 2023 $75K for 819 services; 2024 $70K for 957 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gabriela S Hobbs prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 173 prescriptions and refills. In total Gabriela S Hobbs wrote 733 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 173 | 173 | 27 | $2.7M |
| Hydroxyurea Generic | 136 | 350 | 46 | $3,250 |
| Sprycel Dasatinib | 50 | 50 | 11 | $518K |
| Besremi Ropeginterferon Alfa-2b-Njft | 35 | 35 | Under 11 | $461K |
| Acyclovir Generic | 29 | 55 | Under 11 | $391 |
| Ojjaara Momelotinib Dihydrochloride | 27 | 27 | Under 11 | $765K |
| Bosulif Bosutinib | 26 | 26 | Under 11 | $379K |
| Venclexta Venetoclax | 22 | 22 | Under 11 | $138K |
| Scemblix Asciminib Hydrochloride | 22 | 23 | Under 11 | $452K |
| Imatinib Mesylate Generic | 21 | 21 | Under 11 | $9,706 |
| Inqovi Decitabine/Cedazuridine | 18 | 18 | Under 11 | $143K |
| Pegasys Peginterferon Alfa-2a | 13 | 13 | Under 11 | $14K |
| Gleevec Imatinib Mesylate | 12 | 12 | Under 11 | $32K |
Brand drugs: 471 claims; generic drugs: 262 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gabriela S Hobbs $53K ($53K in general payments such as food, travel and fees) from 15 companies. The largest payer was Sobi, Inc with $13K.
| Company | Payments | Amount |
|---|---|---|
| Sobi, Inc SOBI.ST | 7 | $13K |
| Incyte Corporation INCY | 13 | $12K |
| Merck Sharp & Dohme LLC MRK | 4 | $7,930 |
| Geron Corporation GERN | 9 | $5,561 |
| Karyopharm Therapeutics Inc. KPTI | 2 | $4,890 |
| GlaxoSmithKline, LLC. GSK | 10 | $3,216 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $2,730 |
| Pfizer Inc. PFE | 1 | $2,670 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $274 |
| Taiho Oncology, Inc. 4578.T | 1 | $163 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.